As previously reported14,15, agonistic anti-CD40 monoclonal antibodies effectively suppressed melanoma growth, which was accompanied with a strong induction of expression of anti-tumorigenic genes, but reduced levels of genes related to pro-tumorigenic and tissue-repairing processes in TAMs (Extended Data Fig. 1b–g). Here, CD40 is linked to melanoma.